Relating to the practice of pharmacy, and providing for administrative penalties

Where it is now

1. ✓
   Done: IntroducedFebruary 23, 2023
2. ✓
   Done: SubcommitteeFebruary 23, 2023
3. ✓
   Done: House committeeFebruary 28, 2023
4. ✓
   Done: Passes the HouseMarch 16, 202386–10
5. ✓
   Done: Senate committeeMarch 30, 2023
6. ✓
   Done: Passes the SenateFebruary 26, 202446–0
7. ✓
   Done: To the GovernorApril 19, 2024
8. ✓
   Done: Signed into lawApril 19, 2024

Signed into law What’s a funnel?

Amendments · 4

2 adopted · 0 failed. Newest first.

• H-8202 · filed March 13, 2024 by

  AI summary This amendment adds a rule that pharmacists can swap medications for a device with an equivalent therapeutic effect, as long as the device is in the same class. Its wording →
  Withdrawn
  April 3, 2024
• H-8060 · filed February 26, 2024 by

  AI summary This amendment updates several years from 2023 to 2024 and adds biological products and devices to certain sections of the bill. It prohibits the board from approving protocols that allow pharmacists to order or administer drugs intended to induce an abortion. It also updates the rules regarding which immunizations and point-of-care tests a pharmacist can provide. Its wording →
  Withdrawn
  April 3, 2024
• S-5002 · filed February 5, 2024 by Sen. Jeff Edler (R)

  AI summary This amendment updates several years mentioned in the bill from 2023 to 2024. It also changes the rules regarding what immunizations and vaccinations a pharmacist can order and administer, including specific updates for influenza, COVID-19, and HPV vaccines. Its wording →
  Adopted
  February 26, 2024
• S-3112 · filed March 30, 2023 by

  AI summary This amendment adds biological products and devices to the types of items the board manages and prevents the board from approving protocols that allow pharmacists to order or administer drugs intended to induce an abortion. It also changes the law to prevent health insurance plans from requiring patients to try a generic drug or an interchangeable biological product before covering an equivalent brand-name drug. Its wording →
  Adopted
  February 26, 2024